EMEA-002184-PIP01-17-M01

Table of contents

Key facts

Active substance
Solriamfetol
Therapeutic area
Neurology
Decision number
P/0394/2021
PIP number
EMEA-002184-PIP01-17-M01
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
  • Treatment of narcolepsy
  • Treatment of obstructive sleep apnoea
Route(s) of administration
Oral use
Contact for public enquiries
Jazz Pharmaceuticals Ireland Limited

E-mail: medinfo-int@jazzpharma.com
Tel: 00 44 1865 399 777

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating